Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP1040539.RAjCvComQlU2XW2Lo5IBkeEjdwIuH5GzJ0zj-ykSiNd1U130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP1040539.RAjCvComQlU2XW2Lo5IBkeEjdwIuH5GzJ0zj-ykSiNd1U130_assertion type Assertion NP1040539.RAjCvComQlU2XW2Lo5IBkeEjdwIuH5GzJ0zj-ykSiNd1U130_head.
- NP1040539.RAjCvComQlU2XW2Lo5IBkeEjdwIuH5GzJ0zj-ykSiNd1U130_assertion description "[Hepatitis B surface antigen (HBsAg) seroclearance, a status close to a cure, may also occur in patients with a sustained or maintained viral response, especially in those with IFN-based therapy.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1040539.RAjCvComQlU2XW2Lo5IBkeEjdwIuH5GzJ0zj-ykSiNd1U130_provenance.
- NP1040539.RAjCvComQlU2XW2Lo5IBkeEjdwIuH5GzJ0zj-ykSiNd1U130_assertion evidence source_evidence_literature NP1040539.RAjCvComQlU2XW2Lo5IBkeEjdwIuH5GzJ0zj-ykSiNd1U130_provenance.
- NP1040539.RAjCvComQlU2XW2Lo5IBkeEjdwIuH5GzJ0zj-ykSiNd1U130_assertion SIO_000772 23286854 NP1040539.RAjCvComQlU2XW2Lo5IBkeEjdwIuH5GzJ0zj-ykSiNd1U130_provenance.
- NP1040539.RAjCvComQlU2XW2Lo5IBkeEjdwIuH5GzJ0zj-ykSiNd1U130_assertion wasDerivedFrom befree-2016 NP1040539.RAjCvComQlU2XW2Lo5IBkeEjdwIuH5GzJ0zj-ykSiNd1U130_provenance.
- NP1040539.RAjCvComQlU2XW2Lo5IBkeEjdwIuH5GzJ0zj-ykSiNd1U130_assertion wasGeneratedBy ECO_0000203 NP1040539.RAjCvComQlU2XW2Lo5IBkeEjdwIuH5GzJ0zj-ykSiNd1U130_provenance.